yahoo.com
May 19, 2008
RESEARCH TRIANGLE PARK, NORTH CAROLINA--(MARKET WIRE)--May 19, 2008 -- Adherex Technologies Inc. (AMEX: ), a biopharmaceutical company devoted to solving problems for patients with cancer, announced today the publication of an abstract on the phase I/II study of ADH-1 in combination with isolated...
[read full story]